Your search returned 487 results.

Results
	1.	Re: Shusuke Akamatsu, Masashi Kubota, Ryuji Uozumi, et al. Development and Validation of a Novel Prognostic Model for Predicting Overall Survival in Treatment-naïve Castration-sensitive Metastatic Prostate Cancer. Eur Urol Oncol 2019;2:320-328. [electronic resource] by Mazzone, Elio Karakiewicz, Pierre I Producer: 20200501 In: European urology oncology vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Reply to Giandomenico Roviello, Daniele Generali, and Roberto Petrioli's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033. [electronic resource] by de Bono, Johann S Producer: 20180131 In: European urology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Editorial Comment. [electronic resource] by Todenhöfer, Tilman Producer: 20200723 In: The Journal of urology vol. 204 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033. [electronic resource] by Roviello, Giandomenico Generali, Daniele Petrioli, Roberto Producer: 20180131 In: European urology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033. [electronic resource] by van Soest, Robert J de Wit, Ronald Producer: 20180405 In: European urology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Reply to Piet R. Dirix, Carole Mercier, and Luc Y. Dirix's Letter to the Editor re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51. [electronic resource] by Hölscher, Tobias Lohaus, Fabian Wirth, Manfred Troost, Esther G C Producer: 20200608 In: European urology vol. 76 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Abiraterone in Metastatic Prostate Cancer. [electronic resource] by James, Nicholas D Spears, Melissa R Sydes, Matthew R Producer: 20171031 In: The New England journal of medicine vol. 377 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Low-Dose Abiraterone With Food: Rebutting an Editorial. [electronic resource] by Szmulewitz, Russell Z Karrison, Theodore Stadler, Walter M Ratain, Mark J Producer: 20190911 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate. [electronic resource] by Woei-A-Jin, F J Sherida H Van Nieuwenhuyse, Tine van Erp, Nielka P Beuselinck, Benoit Stroobants, Stephanie Moes, Dirk Jan A R Osanto, Susanne Spriet, Isabel Producer: 20190911 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Abiraterone acetate for metastatic prostate cancer. [electronic resource] by Sonpavde, Guru Producer: 20121207 In: The Lancet. Oncology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033. [electronic resource] by de Bono, Johann Producer: 20180405 In: European urology vol. 71 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Low-Fat Abiraterone Food Effect Is of Little Consequence. [electronic resource] by Kolesar, Jill M Liu, Glenn X Producer: 20190724 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Chemotherapy in frail elderly patients with metastatic castration-resistant prostate cancer? [electronic resource] by Molina-Garrido, Maria-Jose Guillén-Ponce, Carmen Producer: 20180301 In: Urologic oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Low-Fat Abiraterone Food Effect Is of Great Consequence. [electronic resource] by Tannock, Ian F Producer: 20190911 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive. [electronic resource] by Velho, Pedro Isaacsson Eisenberger, Mario A Producer: 20190911 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal". [electronic resource] by Ramaekers, Bram L T Riemsma, Rob Tomini, Florian van Asselt, Thea Deshpande, Sohan Duffy, Steven Armstrong, Nigel Severens, Johan L Kleijnen, Jos Joore, Manuela A Producer: 20190515 In: PharmacoEconomics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Comment on: "Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology Appraisal". [electronic resource] by Reifsnider, Odette Hall, Fiona Sorensen, Sonja Proskorovsky, Irina Girod, Isabelle Lee, Jennifer Producer: 20190515 In: PharmacoEconomics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Author's Reply to Srinivas: "Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer". [electronic resource] by Xu, Steven De Porre, Peter Producer: 20180608 In: Clinical pharmacokinetics vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study. [electronic resource] by O'Reilly, David Producer: 20200114 In: Clinical genitourinary cancer vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets. [electronic resource] by Patel, Amol Tannock, Ian F Srivastava, Priyanka Biswas, Bivas Gupta, Vineet Govinda Batra, Atul Bhethanabhotla, Sainath Pramanik, Raja Mahindru, Shubh Tilak, Tvsvgk Das, Chandan Krishna Mehta, Prashant Producer: 20210728 In: JCO global oncology vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 487 results.